Taken together, the TCGA analyses showed that advanced stage CRC patients have reduced levels of lymphoid and IC genes but importantly, lower expression levels of CD3E, CD8A, TIGIT, and ICOS were associated with poorer PFI. Here, CD3E is linked to colorectal carcinoma.